Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl Davis

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 1, 2021
Calcitonin gene-related peptide (CGRP) receptor antagonists: Heterocyclic modification of a novel azepinone leadGuanglin Luo, Xiang-Jun Jiang, Ling Chen, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Dirty mice better recapitulate key features of mRNA vaccine immunogenicity observed in humansBeatriz Praena, Frances K Shepherd, Cera A McDonald, et al.
Journal of Medicinal Chemistry|March 15, 2021
Discovery of Selective Pituitary Adenylate Cyclase 1 Receptor (PAC1R) Antagonist Peptides Potent in a Maxadilan/PACAP38-Induced Increase in Blood Flow Pharmacodynamic ModelEssa Hu, Fang-Tsao Hong, Jennifer Aral, et al.
Bioorganic & Medicinal Chemistry Letters|May 2, 2013
Discovery of (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide (BMS-742413): a potent human CGRP antagonist with superior safety profile for the treatment of migraine through intranasal deliveryPrasad V Chaturvedula, Stephen E Mercer, Sokhom S Pin, et al.
Minerva Anestesiologica|June 24, 2017
Brain monitoring in adult and pediatric ECMO patients: the importance of early and late assessmentsRoberto Lorusso, Fabio S Taccone, Mirko Belliato, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2025
PD-1 expression identifies proliferating malignant CLL B cells and is a potential biomarker of response to BTK inhibitor therapyAndres Chang, Adam N Pelletier, Donald J McGuire, et al.
Nature Immunology|December 17, 2013
Molecular signatures of antibody responses derived from a systems biology study of five human vaccinesShuzhao Li, Nadine Rouphael, Sai Duraisingham, et al.
Communications Biology|November 9, 2022
Persistent intraocular Ebola virus RNA is associated with severe uveitis in a convalescent rhesus monkeyGabriella Worwa, Timothy K Cooper, Steven Yeh, et al.
Journal of Medicinal Chemistry|July 26, 2014
Discovery of clinical candidate 1-(4-(3-(4-(1H-benzo[d]imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)ethanone (AMG 579), a potent, selective, and efficacious inhibitor of phosphodiesterase 10A (PDE10A)Essa Hu, Ning Chen, Matthew P Bourbeau, et al.
Research Square|January 10, 2024
Anti-Ebola virus mAb 3A6 with unprecedented potency protects highly viremic animals from fatal outcome and physically lifts its glycoprotein target from the virion membraneErica Saphire, Zhe Li Salie, Zunlong Ke, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|May 1, 2021
Calcitonin gene-related peptide (CGRP) receptor antagonists: Heterocyclic modification of a novel azepinone leadGuanglin Luo, Xiang-Jun Jiang, Ling Chen, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Dirty mice better recapitulate key features of mRNA vaccine immunogenicity observed in humansBeatriz Praena, Frances K Shepherd, Cera A McDonald, et al.
Journal of Medicinal Chemistry|March 15, 2021
Discovery of Selective Pituitary Adenylate Cyclase 1 Receptor (PAC1R) Antagonist Peptides Potent in a Maxadilan/PACAP38-Induced Increase in Blood Flow Pharmacodynamic ModelEssa Hu, Fang-Tsao Hong, Jennifer Aral, et al.
Bioorganic & Medicinal Chemistry Letters|May 2, 2013
Discovery of (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide (BMS-742413): a potent human CGRP antagonist with superior safety profile for the treatment of migraine through intranasal deliveryPrasad V Chaturvedula, Stephen E Mercer, Sokhom S Pin, et al.
Minerva Anestesiologica|June 24, 2017
Brain monitoring in adult and pediatric ECMO patients: the importance of early and late assessmentsRoberto Lorusso, Fabio S Taccone, Mirko Belliato, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2025
PD-1 expression identifies proliferating malignant CLL B cells and is a potential biomarker of response to BTK inhibitor therapyAndres Chang, Adam N Pelletier, Donald J McGuire, et al.
Nature Immunology|December 17, 2013
Molecular signatures of antibody responses derived from a systems biology study of five human vaccinesShuzhao Li, Nadine Rouphael, Sai Duraisingham, et al.
Communications Biology|November 9, 2022
Persistent intraocular Ebola virus RNA is associated with severe uveitis in a convalescent rhesus monkeyGabriella Worwa, Timothy K Cooper, Steven Yeh, et al.
Journal of Medicinal Chemistry|July 26, 2014
Discovery of clinical candidate 1-(4-(3-(4-(1H-benzo[d]imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)ethanone (AMG 579), a potent, selective, and efficacious inhibitor of phosphodiesterase 10A (PDE10A)Essa Hu, Ning Chen, Matthew P Bourbeau, et al.
Research Square|January 10, 2024
Anti-Ebola virus mAb 3A6 with unprecedented potency protects highly viremic animals from fatal outcome and physically lifts its glycoprotein target from the virion membraneErica Saphire, Zhe Li Salie, Zunlong Ke, et al.
Pageof 5